These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 32241057)
1. [The research progress in clinicopathological characteristics and treatment of hepatitis B virus-associated intrahepatic cholangiocarcinoma]. Tang ZH; Tong HJ; Quan ZW Zhonghua Wai Ke Za Zhi; 2020 Apr; 58(4):280-283. PubMed ID: 32241057 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Zhou H; Wang H; Zhou D; Wang H; Wang Q; Zou S; Tu Q; Wu M; Hu H Eur J Cancer; 2010 Apr; 46(6):1056-61. PubMed ID: 20202823 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus infection and intrahepatic cholangiocarcinoma. Zhou HB; Hu JY; Hu HP World J Gastroenterol; 2014 May; 20(19):5721-9. PubMed ID: 24914333 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Jeong S; Tong Y; Sha M; Gu J; Xia Q Oncotarget; 2017 Mar; 8(10):17292-17300. PubMed ID: 28030846 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection. Zhou HB; Wang H; Li YQ; Li SX; Wang H; Zhou DX; Tu QQ; Wang Q; Zou SS; Wu MC; Hu HP World J Gastroenterol; 2011 Mar; 17(10):1292-303. PubMed ID: 21455328 [TBL] [Abstract][Full Text] [Related]
6. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis. Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237 [TBL] [Abstract][Full Text] [Related]
7. Role of Intravoxel Incoherent Motion in Discriminating Hepatitis B Virus-Related Intrahepatic Mass-Forming Cholangiocarcinoma from Hepatocellular Carcinoma Based on Liver Imaging Reporting and Data System v2018. Shao S; Shan Q; Zheng N; Wang B; Wang J Cancer Biother Radiopharm; 2019 Oct; 34(8):511-518. PubMed ID: 31314589 [No Abstract] [Full Text] [Related]
8. Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis. Wang Z; Sheng YY; Dong QZ; Qin LX World J Gastroenterol; 2016 Mar; 22(10):3038-51. PubMed ID: 26973400 [TBL] [Abstract][Full Text] [Related]
9. Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection. Huang J; Wang X; Zhu Y; Wang Z; Li J; Xu D; Wang S; Li TE; Lu L J Surg Oncol; 2019 Jan; 119(1):40-46. PubMed ID: 30480811 [TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical characteristics of combined hepatocellular-cholangiocarcinoma and other primary liver cancers. Lee CH; Hsieh SY; Chang CJ; Lin YJ J Gastroenterol Hepatol; 2013 Jan; 28(1):122-7. PubMed ID: 23034166 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus-related combined hepatocellular-cholangiocarcinoma: clinicopathological and prognostic analysis of 390 cases. Chu KJ; Lu CD; Dong H; Fu XH; Zhang HW; Yao XP Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):192-9. PubMed ID: 24370644 [TBL] [Abstract][Full Text] [Related]
12. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma. Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728 [TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of hepatitis B virus infection in patients with intrahepatic cholangiocarcinoma. Ahn CS; Hwang S; Lee YJ; Kim KH; Moon DB; Ha TY; Song GW; Lee SG ANZ J Surg; 2018 Mar; 88(3):212-217. PubMed ID: 27598539 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand. Songsivilai S; Dharakul T; Kanistanon D Trans R Soc Trop Med Hyg; 1996; 90(5):505-7. PubMed ID: 8944256 [TBL] [Abstract][Full Text] [Related]
15. Comparing the clinicopathological characteristics of combined hepatocellular-cholangiocarcinoma with those of other primary liver cancers by use of the updated World Health Organization classification. Yen CC; Yen CJ; Shan YS; Lin YJ; Liu IT; Huang HY; Yeh MM; Chan SH; Tsai HW Histopathology; 2021 Oct; 79(4):556-572. PubMed ID: 33837585 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and intrahepatic cholangiocarcinoma. Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558 [TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological features of combined hepatocellular-cholangiocarcinoma compared with other liver cancers. Wakizaka K; Yokoo H; Kamiyama T; Ohira M; Kato K; Fujii Y; Sugiyama K; Okada N; Ohata T; Nagatsu A; Shimada S; Orimo T; Kamachi H; Taketomi A J Gastroenterol Hepatol; 2019 Jun; 34(6):1074-1080. PubMed ID: 30462849 [TBL] [Abstract][Full Text] [Related]
19. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis]. Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776 [No Abstract] [Full Text] [Related]
20. Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus. Peng NF; Li LQ; Qin X; Guo Y; Peng T; Xiao KY; Chen XG; Yang YF; Su ZX; Chen B; Su M; Qi LN Ann Surg Oncol; 2011 May; 18(5):1258-66. PubMed ID: 21207172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]